CytoMed Therapeutics GDTC Balance Sheet (2020-2026)

NASDAQ GDTC
$0.84 +0.00 (+0.49%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

CytoMed Therapeutics Quarterly Balance Sheet

Periods 11 quarters
Latest Jun 2026

CytoMed Therapeutics reported total assets of $5.42M and total liabilities of $1.25M for the quarter ended Jun 2026, down 32.7% year over year. This balance sheet covers 11 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2020 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.67M1.86M1.07M1.18M7.72M6.82M4.78M3.66M2.24M1.63M1.13M
Short-term InvestmentsInvestments (Current) 0.51M0.92M0.80M3.00M
Cash & Current Investments 0.67M1.86M1.07M1.68M7.72M7.74M4.78M4.46M2.24M4.63M1.13M
Receivables - NetNet Receivables 0.57M0.68M0.83M0.76M0.97M1.22M1.37M
Receivables - OtherOther Receivables 0.04M0.02M0.11M0.76M0.20M0.91M0.37M-0.14M0.38M0.05M
Receivables 0.58M0.79M1.03M1.13M0.82M1.60M1.43M
Prepaid Assets 0.26M0.25M
Current Assets 2.43M1.86M8.48M7.65M5.69M4.41M3.21M2.85M2.50M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 2.45M1.85M1.84M1.64M1.56M1.83M2.39M2.73M2.88M2.82M
Long-Term Investments 0.20M0.18M0.16M0.15M0.16M0.16M0.17M
Intangibles 0.05M0.02M0.01M0.01M0.01M0.01M0.07M0.06M0.10M0.08M
Goodwill & Intangibles 0.05M0.02M0.01M0.01M0.01M0.01M0.07M0.06M0.10M0.08M
Other Non-Current Assets -2.10M0.37M0.02M0.02M
Non-Current Assets 2.07M2.03M1.81M1.72M2.07M2.98M3.36M3.36M2.92M
Assets 4.50M3.89M10.29M9.37M8.05M7.41M6.57M6.22M5.42M
Liabilities
Current Liabilities
Accounts Payables 0.16M0.31M0.20M0.40M0.23M0.32M0.38M0.35M0.80M
Notes Payables 0.29M0.25M0.02M0.03M0.03M0.03M0.03M0.03M0.03M
Payables 0.45M0.56M0.22M0.42M0.26M0.35M0.41M0.38M0.83M
Other Accumulated Expenses 0.22M
Short term Debt 1.71M2.53M
Current Taxes 0.00M0.32M0.31M0.29M0.29M0.27M
Current Deferred Revenue 0.01M0.00M0.00M0.00M0.00M0.08M0.06M0.14M0.08M
Total Current Liabilities 2.17M3.10M0.23M0.54M0.26M0.45M0.55M0.55M0.95M
Non-Current Liabilities
Capital Leases -0.02M-0.05M
Non-Current Debt 0.40M0.35M0.32M0.31M0.29M0.29M0.29M0.29M
Minority Interest -324.73-507.62-608.00-724.35-812.000.06M0.06M0.24M0.33M
Operating Leases 0.01M0.00M0.01M0.00M0.00M0.02M0.02M0.04M0.02M
Other Non-Current Liabilities 0.11M0.01M0.07M0.02M0.02M
Total Non-Current Liabilities 0.41M0.35M0.32M0.31M0.29M0.31M0.34M0.33M0.30M
Total Liabilities 2.58M3.45M0.55M0.85M0.55M0.75M0.89M0.88M1.25M
Shareholder's Equity
Total Debt 2.39M3.13M0.34M0.33M0.31M0.32M0.32M0.32M0.03M
Common Equity 0.36M1.92M0.44M9.74M8.52M7.50M6.65M5.68M5.34M4.17M
Liabilities and Shareholders Equity 4.50M3.89M10.29M9.37M8.05M7.41M6.57M6.22M5.42M
Retained Earnings -3.75M-6.10M-7.66M-9.34M-9.90M-10.92M-13.44M-14.67M-15.92M

CytoMed Therapeutics Balance Sheet API

Pull CytoMed Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GDTC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY